US 7312226
Substituted tricyclic compounds as protein kinase inhibitors
granted A61PA61P35/00A61P35/04
Quick answer
US patent 7312226 (Substituted tricyclic compounds as protein kinase inhibitors) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P35/00, A61P35/04, A61P43/00